Mike Hsu

North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal

by | Nov 3, 2025
New Jersey-based Kenvue—which spun off from Johnson & Johnson in 2023—is the maker of Tylenol, whose active ingredient, acetaminophen, has been linked to autism by the Trump administration. Kimberly-Clark CEO Mike Hsu says the unique combination of CPG and healthcare brands "will serve billions of consumers across every stage of life."
MORE
North Texas’ Kimberly-Clark Sells Majority Stake in Its Int’l Tissue Business to Brazil’s Suzano for $1.73B
by | Jun 5, 2025
Irving-based Kimberly-Clark will maintain a 49% interest in the new joint venture, which is valued at $3.4 billion. The company said it is sharpening its focus on its "higher growth, higher margin businesses."
MORE
Kimberly-Clark Promotes Key Leader to President and COO Amid $2B Investment Plan
by | May 6, 2025
Russ Torres will lead global operations and partner with CEO Mike Hsu to accelerate Kimberly-Clark’s transformation and Powering Care growth strategy, the company said.
MORE